https://alembicpharmaceuticals.com/ 2026-02-23T06:36:14+00:00 1.00 https://alembicpharmaceuticals.com/about-us 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/contact-us 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/corporate-profile 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/journey 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/board-of-directors 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/subsidiaries-and-associates 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/accolades 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/duns-certificates 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/assets/pdf/extract-of-form-5a-alembic-pharmaceuticals-limited.pdf 2025-10-13T09:55:09+00:00 0.80 https://alembicpharmaceuticals.com/business 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/india-formulations 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/international-generics 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/active-pharmaceutical-ingredients 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/capabilities 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/manufacturing 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/research-and-development 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/quality-and-compliance 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/investors 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/quarterly-results 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/annual-reports 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/webfiles/pdf/investor/business-update/Business-update-on-financial-year-21-22.pdf 2023-06-29T06:22:50+00:00 0.80 https://alembicpharmaceuticals.com/sustainability-reports 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/subsidiary-financials 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/governance-philosophy 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/committees-composition 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/policies-and-codes 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/responsibility 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/assets/pdf/investor/disclosure-under-regulation-46-of-sebi-lodr-regulations/Familiarization-Programme.pdf?1 2026-02-06T08:06:05+00:00 0.80 https://alembicpharmaceuticals.com/shareholder-services 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/iepf 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/unpaid-unclaimed-dividend 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/investor-related-forms 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/tds-on-dividend 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/saksham-niveshak-100-days-campaign 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/assets/pdf/Special-Window-for-transfer-and-dematerialization-of-physical-securities.pdf 2026-02-16T11:31:37+00:00 0.80 https://alembicpharmaceuticals.com/investor-relations 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/sustainability 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/overview 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/materiality-assessment 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/assets/pdf/climate-risk-assessment-report-alembic-pharmaceuticals-limited.pdf?1 2025-12-29T12:26:02+00:00 0.80 https://alembicpharmaceuticals.com/alembic-events-details 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/esg-ratings 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/awards-disclosure 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/reports 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/environment 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/ghg-emission 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/sustainability-water 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/hazardous-and-non-hazardous-waste 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/compliance-report 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/environment-policies 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/sustainability-social 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/sustainability-reports-social 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/governance 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/corporate-policies 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/sustainable-procurement 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/csr 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/health 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/education 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/livelihood 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/art-and-culture 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/media-coverage 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/careers 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/life-at-alembic 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/media 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/assets/pdf/APL-Revised-MRP-List-GST-2.0-wef-22nd-Sep-25-V1.pdf 2025-09-19T07:23:06+00:00 0.80 https://alembicpharmaceuticals.com/press-releases 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/news-insights 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/alembic-gallery 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/reporting-side-effect 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/assets/pdf/investor/Sustainability-Report-2022-23.pdf 2025-01-18T10:52:33+00:00 0.80 https://alembicpharmaceuticals.com/ask-tara 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/privacy-policy 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/terms-of-use 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/disclaimer 2026-02-23T06:36:14+00:00 0.80 https://alembicpharmaceuticals.com/sitemap.html 2026-02-16T11:37:05+00:00 0.80 https://alembicpharmaceuticals.com/assets/pdf/about/Alembic-AR-2020-21_Deluxe-version_15.06.2021.pdf 2023-04-26T07:23:48+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/about/Alembic-Pharmaceuticals-Limited-Annual-Report-2019-20.pdf 2023-04-26T07:23:56+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/about/Alembic-Pharmaceuticals-Limited-Annual-Report-2018-19.pdf 2023-04-26T07:23:48+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/duns-and-ratings-certificates-alembic-pharmaceuticals-limited.pdf 2025-12-09T06:20:32+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/duns-certificates/executive-summary-vantage-plus-alembic-pharmaceuticals-limited.pdf 2025-12-08T13:16:06+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/duns-certificates/DUNS-Rating-certificate-Alembic-Pharmaceuticals-Limited.pdf 2024-10-03T05:18:14+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/duns-certificates/Post-revert-Alembic-Pharmaceuticals-Limited-Vantage-Plus-Report-02-09-2024.pdf 2024-10-03T05:18:52+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/investor/annual-reports/2024-2025/Q2/Annual-Report-2024-2025.pdf 2025-06-16T06:28:03+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/investor/annual-reports/2023-2024/Q1/Annual-Report-2023-2024.pdf 2025-03-06T05:04:49+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/investor/annual-reports/2022-2023/Q2/Alembic-Interactive-AR-2023-final-SP-high.pdf 2023-07-10T12:05:54+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/investor/annual-reports/2021-2022/Q1/Alembic-Pharmaceuticals-Limited-Annual-Report-2021-22.pdf 2023-07-03T09:56:24+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/investors_presentations/2025-2026/Q3/Investor-Presentation-December-2025.pdf 2026-02-05T10:41:45+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/investors_presentations/2025-2026/Q2/Investor-Presentation-September-2025.pdf 2025-11-04T10:04:23+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/investors_presentations/2025-2026/Q1/Investor-Presentation-June-2025.pdf 2025-08-05T08:47:02+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/investors_presentations/2024-2025/Q4/Investor-Presentation-March-2025.pdf 2025-05-06T09:14:25+00:00 0.64 https://alembicpharmaceuticals.com/iepf-and-unpaid-unclaimed-dividend 2026-02-23T06:36:14+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/investor/investor-relations/SEBI%20Circulars%20on%20Online%20Dispute%20Resolution.pdf 2023-11-24T11:02:43+00:00 0.64 https://alembicpharmaceuticals.com/view-archive-financial-information 2026-02-23T06:36:14+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/annual-reports/2024-2025/Q2/Annual-Report-2024-2025.pdf 2025-06-16T06:28:03+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/annual-reports/2023-2024/Q1/Annual-Report-2023-2024.pdf 2025-03-06T05:04:49+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/annual-reports/2022-2023/Q2/Alembic-Interactive-AR-2023-final-SP-high.pdf 2023-07-10T12:05:54+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/annual-reports/2021-2022/Q1/Alembic-Pharmaceuticals-Limited-Annual-Report-2021-22.pdf 2023-07-03T09:56:24+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/annual-reports/2020-2021/Q1/Alembic-Pharmaceuticals-Limited-Annual-Report-2020-21.pdf 2023-07-03T09:55:06+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/sustainability-report/2024-2025/Q3/sustainability-report-2024-2025.pdf 2025-12-30T11:41:50+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/sustainability-report/2023-2024/Q3/Sustainability-Report-2023-24.pdf 2025-11-14T05:19:17+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/sustainability-report/2022-2023/Q3/Sustainability-Report-2022-23.pdf 2025-11-14T05:18:11+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/TicTwo%20Therapeutics%20Inc.pdf 2025-06-13T11:44:37+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/Alnova%20Pharmaceuticals%20SA.pdf 2025-06-13T11:44:22+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/Alembic%20Pharmaceuticals%20SA%20DE%20CV.pdf 2025-06-13T11:44:06+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/Alembic%20Pharmaceuticals%20Inc.pdf 2025-06-13T11:43:25+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/Alembic%20Pharmaceuticals%20Europe%20Ltd.pdf 2025-06-13T11:43:05+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/Alembic%20Pharmaceuticals%20Chile%20SpA.pdf 2025-06-13T11:40:39+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/Alembic%20Pharmaceuticals%20Australia%20Pty%20Ltd.pdf 2025-06-13T11:40:16+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/Alembic%20Phamaceuticals%20Canada.pdf 2025-06-13T11:39:07+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/Alembic%20Global%20Holding%20SA.pdf 2025-06-13T11:36:39+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/Incozen%20Therapeutics%20Private%20Limited.pdf 2025-06-13T11:50:13+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/Rhizen%20Pharmaceuticals%20AG.pdf 2025-06-13T11:49:52+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/Rhizen%20Pharmaceuticals%20AG%20(DMCC%20Branch).pdf 2025-06-13T11:49:38+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/subsidiaries-associates/2024-2025/Dahlia%20Therapeutics%20SA.pdf 2025-06-13T11:47:47+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/APL-Policy-on-Board-Diversity.pdf 2026-01-13T08:15:45+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/APL-Risk-Management-Policy-2025.pdf 2026-01-13T08:14:09+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/ANTI-CORRUPTION-AND-ANTI-BRIBERY-POLICY.pdf 2024-07-08T06:44:17+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/EHS-Policies.pdf 2024-07-08T06:53:55+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/Archival%20Policy.pdf 2023-12-07T10:41:14+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/2-CSR-Policy-1.pdf 2023-07-10T10:14:12+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/3-Code-of-Conduct.pdf 2025-04-03T04:54:41+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/Code-of-Practices-and-Procedures-for-Fair-Disclosure-of-Unpublished-Price-Sensative-Information.pdf 2025-05-22T04:10:25+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/APL-Dividend%20Distribution%20Policy.pdf 2023-12-07T10:42:07+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/Nomination%20and%20Remuneration%20Policy.pdf 2025-04-03T04:52:02+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/Policy%20for%20Determination%20of%20Materiality.pdf 2025-04-03T04:53:15+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/Policies_on_Business_Responsibility.pdf 2024-12-20T09:34:08+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/policy-on-ethics.pdf 2024-10-04T11:01:30+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/policy-on-product-sustainability.pdf 2024-10-04T11:08:44+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/policy-on-employee-well-being.pdf 2024-10-04T11:10:12+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/policy-on-stakeholder.pdf 2024-10-04T11:11:28+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/policy-on-human-right.pdf 2024-10-04T11:12:43+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/policy-on-environment.pdf 2024-10-04T11:14:22+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/policy-on-advocacy.pdf 2024-10-04T11:15:31+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/policy-on-community-development.pdf 2024-10-04T11:16:52+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/policy-on-%20customer-value.pdf 2024-10-04T11:20:08+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/9-Policy-on-Material-Subsidiaries.pdf 2025-04-03T04:54:09+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/10-RPT-Policy-1.pdf 2025-04-03T04:46:45+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/11-APL-Terms-Conditions-Appointment-Independent-Directors.pdf 2023-07-10T10:10:34+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/Whistle-Blower-Policy.pdf 2026-01-06T13:20:06+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/governance-philosophy/Policy%20on%20Preservation%20of%20Documents.pdf 2023-12-07T10:39:22+00:00 0.64 https://alembicpharmaceuticals.com/investors-grievances-redressal 2026-02-23T06:36:14+00:00 0.64 https://alembicpharmaceuticals.com/registrar-transfer-agents 2026-02-23T06:36:14+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/iepf/Details%20of%20Shareholders%20whose%20shares%20wil%20be%20transferred%20during%20the%20FY%202024-25.pdf 2024-04-30T07:09:24+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/unpaid-unclaimed-dividend/Deatils-Of-Unpaid-Unclaimed-Dividend-For-The-FY-2017-18-To-2023-24.pdf 2025-09-29T11:32:04+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/unpaid-unclaimed-dividend/Details-Of-Unpaid-Unclaimed-Dividend-For-The-FY-2024-25.pdf 2025-10-10T11:08:46+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/investor-related-forms/Form-ISR-1.pdf 2023-07-08T09:14:19+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/investor-related-forms/Form-ISR-2.pdf 2023-07-08T09:14:09+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/investor-related-forms/Form-ISR-3.pdf 2023-07-08T09:13:58+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/investor-related-forms/Form-ISR-4.pdf 2023-07-08T09:13:45+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/investor-related-forms/Form-No-SH-13.pdf 2023-07-08T09:13:24+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/investor-related-forms/Form-No-SH-14.pdf 2023-07-08T09:11:42+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/investor/tds-on-dividend/deduction-of-tax-on-dividend-as-per-income-tax-act-1961.pdf 2023-07-08T07:09:38+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/investor/tds-on-dividend/Declaration-as-per-Rule-37BC.pdf 2023-07-08T07:09:38+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/investor/tds-on-dividend/Declaration-for-No-Permanent-Establishment.pdf 2023-07-08T07:09:38+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/investor/tds-on-dividend/Form-No-10F.pdf 2023-07-08T07:09:38+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/investor/tds-on-dividend/Form-No-15G.pdf 2023-07-08T07:09:38+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/investor/tds-on-dividend/Form-No-15H.pdf 2023-07-08T07:09:38+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/saksham-niveshak-100-days-campaign.pdf 2025-10-06T09:38:38+00:00 0.64 https://alembicpharmaceuticals.com/sustainability-environment 2026-02-23T06:36:14+00:00 0.64 https://alembicpharmaceuticals.com/assets/img/sustainability/Alembic-Pharmaceuticals-Limited-Net-Zero-Approval-Letter-Monday-24-February-2025.pdf 2025-04-25T11:36:25+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/TfS-Certificate-Alembic-Pharmaceuticals.pdf 2024-10-10T12:35:55+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/API-1_TFS-Audit-Report.pdf 2024-09-17T10:16:14+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/F-1_TFS-Audit-report.pdf 2024-09-17T10:16:43+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/F-2_TFS-Audit-report.pdf 2024-09-17T10:16:15+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/reports/Assurance-Statement-of-Sustainability-Report-(SR)-for-FY-2024-25.pdf 2025-11-28T13:15:55+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/reports/Sustainability-Report-2022-23.pdf 2024-01-23T05:33:51+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/reports/Alembic_Sustainability_Report_Financial_Year_2023-24.pdf 2024-12-23T10:00:59+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/reports/sustainability-report-2024-2025.pdf?1 2026-01-01T11:44:09+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/reports/Assurance-Statement-of-Business-Responsibility-and-Sustainability-Report-(BRSR)-for-FY-2024-25.pdf 2025-11-28T13:16:03+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/reports/Alembic-Interactive-AR-2023-final-SP-high.pdf 2024-01-23T05:29:15+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/reports/Business-Responsibilities-And-Sustainability-Reporting-Annual-Report%E2%80%932023-24.pdf 2025-03-04T09:36:39+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/reports/Business-Responsibility-and-Sustainability-Reporting-(BRSR)-Assurance-Statement-of-FY-2023-24.pdf 2024-10-15T10:40:14+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/API-1-EC-Compliance-MoEF&CC-April,2024-to-September,2024.pdf 2025-03-04T06:40:29+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/sustainability/API-1-EC-Compliance-April-2024-to-September-2024.pdf 2025-02-26T11:26:03+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/sustainability/EC_Compliance.pdf 2024-02-09T06:33:01+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/API-2-EC-Compliance_SEIAA.pdf 2025-03-04T06:40:31+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/API-2-EC-Compliance_MoEF&CC.pdf 2025-03-04T06:40:29+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/sustainability/API-2-EC.pdf 2024-02-14T10:52:28+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/sustainability/API-3-EC-Compliance-Report-July-2024-to-December-2024.pdf 2025-02-26T11:25:47+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/sustainability/API-3_EC-complience-Jan-2023-to-Jun-2023.pdf 2024-01-19T11:48:12+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/Antimicrobial-Resistance-AMR-Policy.pdf 2026-01-13T08:35:10+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/Biodiversity-Policy-and-No-Deforestation-Commitment.pdf 2026-01-13T08:35:10+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-social-responsibility/CSR-Policy.pdf 2023-07-10T10:44:47+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/sustainability/CSR-Annual-Action-Plan-2025-26.pdf 2025-07-23T04:42:10+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-social-responsibility/CSR-Annual-Action-Plan-F.Y-2024-25.pdf 2025-02-12T09:50:47+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-social-responsibility/Annual-Action-Plan-for-CSR-F.Y.-2023-24.pdf 2024-05-13T05:32:06+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-social-responsibility/Annual-Action-Plan-for-CSR-F.Y.-2022-23.pdf 2023-07-10T10:44:04+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/sustainability/Impact-Assesment-Report-FY-2024-25.pdf 2025-05-19T11:38:45+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/sustainability/Impact-Assessment-Report-2023-24.pdf 2024-07-12T13:13:45+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/sustainability/Impact-Assessment-Report-2022-23.pdf 2024-01-19T11:19:57+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/ANTI-CORRUPTION-AND-ANTI-BRIBERY-POLICY.pdf 2024-07-08T06:44:17+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/EHS-Policies.pdf 2024-07-08T06:53:55+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/Archival%20Policy.pdf 2024-07-08T06:57:17+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/2-CSR-Policy-1.pdf 2024-07-08T06:58:12+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/3-Code-of-Conduct.pdf 2024-07-08T06:58:48+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/4-Code-of-Practices-and-Procedures-for-Fair-Disclosure-of-Unpublished-Price-Sensitive-Information.pdf 2025-05-09T12:59:03+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/APL-Dividend%20Distribution%20Policy.pdf 2024-07-08T07:00:18+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/6-Nomination-and-Remuneration-Policy.pdf 2024-07-08T07:00:45+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/Policy%20for%20Determination%20of%20Materiality.pdf 2024-10-05T06:46:33+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/Policies_on_Business_Responsibility.pdf 2024-12-20T09:31:47+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/policy-on-ethics.pdf 2024-10-03T12:08:24+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/policy-on-product-sustainability.pdf 2024-10-03T12:08:39+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/policy-on-employee-well-being.pdf 2024-10-03T12:08:53+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/policy-on-stakeholder.pdf 2024-10-03T12:09:06+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/policy-on-human-right.pdf 2024-10-03T12:09:19+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/policy-on-environment.pdf 2024-10-03T12:09:35+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/policy-on-advocacy.pdf 2024-10-03T12:09:53+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/policy-on-community-development.pdf 2024-10-03T12:10:04+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/policy-on-%20customer-value.pdf 2024-10-03T12:10:19+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/9-Policy-on-Material-Subsidiaries.pdf 2024-07-08T07:01:50+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/10-RPT-Policy-1.pdf 2024-07-08T07:02:07+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/11-APL-Terms-Conditions-Appointment-Independent-Directors.pdf 2024-07-08T07:02:25+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/Whistle-Blower-Policy.pdf 2026-01-06T13:12:46+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/pdf/Investor/corporate-policy/Policy%20on%20Preservation%20of%20Documents.pdf 2024-07-08T07:03:21+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/sustainability/Sustainable-Procurement-Policy.pdf 2024-01-25T08:38:19+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/sustainability/Alembic_Supplier_Code_of_Conduct.pdf 2024-06-05T12:28:25+00:00 0.64 https://alembicpharmaceuticals.com/assets\pdf\press-releases\Press-Release-Aleor-USFDA-Final-Approval-Metronidazole-Gel-USP-September-2021.pdf 2023-04-26T07:23:54+00:00 0.64 https://alembicpharmaceuticals.com/assets\pdf\press-releases\Press-Release-USFDA-Final-Approval-Clomipramine-Hydrochloride-Capsules-USP-August-2021.pdf 2023-04-26T07:23:56+00:00 0.64 https://alembicpharmaceuticals.com/assets\pdf\press-releases\Press-Release-USFDA-Final-Approval-Erlotinib-Tablets-July-2021.pdf 2023-04-26T07:23:58+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-Carbidopa-Levodopa-and-Entacapone-Tablets.pdf 2026-02-06T07:16:34+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-December-2025.pdf 2026-02-05T10:40:47+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-Difluprednate-Ophthalmic-Emulsion.pdf 2026-02-06T07:23:08+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press%20Release_Bosutinib%20Tablets,%20400%20mg.pdf 2026-01-12T08:32:12+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-Travoprost-Ophthalmic-Solution.pdf 2025-12-18T05:57:46+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-Loteprednol-Etabonate-and-Tobramycin-Ophthalmic.pdf 2025-12-11T08:09:01+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-Diltiazem-Hydrochloride-Tablets.pdf 2025-11-17T04:37:20+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-Dexlansoprazole-Delayed-Release-Capsules.pdf 2025-11-13T06:55:22+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/PR-Sumatriptan-Injection-USP-Single-Dose-Autoinjector-System.pdf 2025-11-10T08:10:59+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-Dasatinib-Tablets.pdf 2025-11-07T08:10:52+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-September-2025.pdf 2025-11-04T10:03:08+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/press-release-ticagrelor-tablets.pdf 2025-10-30T03:46:57+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-Triamcinolone-Acetonide-Injectable-Suspension.pdf 2025-10-24T05:23:08+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-for-Paroxetine-Extended-Release-Tablets-USP-25mg-and-37-mg.pdf 2025-09-25T08:44:54+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-for-Phytonadione-Injectable-Emulsion.pdf 2025-09-09T08:29:07+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-for-Carbamazepine-Extended-Release-Tablets.pdf 2025-08-16T05:05:41+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-For-Tretinoin-Cream-USP-0.025.pdf 2025-09-09T08:39:12+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-release-June-2025.pdf 2025-08-05T08:45:30+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-for-Doxorubicin-Hydrochloride-Liposome-Injection.pdf 2025-06-30T04:34:22+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-for-Final-Approval-of-Bosutinib-Tablets-100mg-and-500mg.pdf 2025-05-31T04:31:59+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-for-Final-Approval-of-Amlodipine-and-Atorvastatin-Tablets.pdf 2025-05-23T09:20:50+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-for-final-approval-of-Rivaroxaban-Tablets-2mg-10mg-15mg-and-20mg.pdf 2025-05-15T09:16:18+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press-release-March-2025.pdf 2025-05-06T09:12:53+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-for-Final-Approval-for-Ticagrelor-Tablets-90mg-and-Tentative-Approval-for-Ticagrelor-Tablets-60-mg.pdf 2025-05-02T09:15:58+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-FA-for-Carbamazepine-Tablets-USP-200-mg.pdf 2025-04-17T06:37:21+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2025-2026/Press-Release-FA-for-Pantoprazole-Sodium-injection-40-mgvial-(Single-Dose-Vial).pdf 2025-04-01T12:38:40+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Alembic-Pharmaceuticals-Ltd-Amlan-International-FV.pdf 2025-03-25T08:30:53+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press-release-December-2024.pdf 2025-02-03T09:39:53+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press-Release-FA-for-Brexpiprazole-Tablets.pdf 2025-01-16T05:37:07+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press-Release-FA-for-Divalproex-Sodium-Delayed-Release-Capsules-USP-125-mg.pdf 2024-12-20T08:49:37+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press%20Release%20TA%20for%20Olopatadine%20Hydrochloride%20Ophthalmic%20Solution%20USP.pdf 2024-12-04T08:38:37+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press-Release-FA-for-Ivabradine-Tablets-5-mg-and-7_5-mg.pdf 2024-11-12T10:45:12+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press-Release-FA-for-Hydrochloride-Extended-Release-Capsules-USP.pdf 2024-11-11T09:54:11+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Alembic%20Pharmaceutical%20Ltd.%20Q2%20FY25%20Financial%20results%20press%20release.pdf 2024-11-07T12:52:42+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press%20Release%20APL%20FA%20for%20Diltiazem%20Hydrochloride%20Extended%20Release%20Capsule,%2020th%20October,%202024.pdf 2024-10-21T07:17:25+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press%20Release%20FA%20for%20Alcaftadine%20Ophthalmic%20Solution%20OTC.pdf 2024-10-04T09:03:31+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press%20Release%20Final%20Approval%20for%20Lamotrigine%20Extended%20Release%20Tablets.pdf 2024-10-03T04:36:10+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press%20Release%20APL%20FA%20for%20Paliperidone%20Extended%20Release%20Tablets.pdf 2024-09-30T04:59:20+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press%20Release%20USFDA%20Final%20Approval%20for%20Albendazole%20Tablets%20USP%20200%20mg.pdf 2024-09-05T09:50:23+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press_Release_APL_FA_for_BetamethasoneValerate_mg.pdf 2024-08-24T11:28:04+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press_Release_USFDA_FA_for_Dabigatran_Etexilate_Capsules_110_mg.pdf 2024-08-13T07:07:48+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press%20Release%20-Q-1%20FY%2025_v1.pdf 2024-08-08T09:20:19+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press_Release_USFDA_FA_for_Acitretin_Capsules_USP_10_mg_17.5_mg_and_25_mg.pdf 2024-08-07T08:52:17+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press_Release_USFDA_FA_Nelarabine_Injection_250mg50%20mL5mgmL_SingleDoseVial.pdf 2024-08-03T08:32:25+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press_Release_USFDA_FA_Fluphenazine_Hydrochloride_Tablets_USP_1_mg_2.5_mg_5%20mg_and_10mg_24th%20Juy,2024.pdf 2024-07-24T08:37:49+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press%20Release%20USFDA%20Tenatative%20Approval%20Selexipag%20for%20Injection%201800%20mcgvial%2012th%20Juy2024.pdf 2024-07-12T12:54:47+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press-Release-USFDA-Final-Approval-for-Bromfenac-Ophthalmic-Solution-9th-July-2024.pdf 2025-04-28T10:16:00+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press%20Release%20USFDA%20Tenatative%20Approval%20Ivosidenib%20Tablets%204th%20Juy,2024.pdf 2024-07-04T10:46:47+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press%20Release%20USFDA%20Tenatative%20Approval%20Bosutinib%20Tablets%201st%20Juy,2024.pdf 2024-07-01T05:54:05+00:00 0.64 https://alembicpharmaceuticals.com/webfiles/media/2024-2025/Press%20Release%20USFDA%20Final%20Approval%20Doxycycline%20Capsules%2028th%20June,2024.pdf 2024-06-28T08:17:23+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/investor/disclosure-under-regulation-46-of-sebi-lodr-regulations/Familiarization-Programme.pdf 2026-02-06T08:06:05+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/climate-risk-assessment-report-alembic-pharmaceuticals-limited.pdf 2025-12-29T12:26:02+00:00 0.64 https://alembicpharmaceuticals.com/community 2026-02-23T06:36:14+00:00 0.64 https://alembicpharmaceuticals.com/assets/pdf/iepf-and-unpaid-unclaimed-dividend/Details-of-Shareholders-(F.Y.-2021-22).pdf 2023-07-29T09:44:02+00:00 0.51 https://alembicpharmaceuticals.com/assets/pdf/iepf-and-unpaid-unclaimed-dividend/Form-IEPF-5.pdf 2023-07-29T09:44:02+00:00 0.51 https://alembicpharmaceuticals.com/assets/pdf/iepf-and-unpaid-unclaimed-dividend/APL-Details-Unclaimed-Unpaid-Interim-Dividend-F.Y.2019-2020.pdf 2023-07-29T09:44:02+00:00 0.51 https://alembicpharmaceuticals.com/assets/pdf/iepf-and-unpaid-unclaimed-dividend/APL-Details-Unclaimed-Unpaid-Dividend-Matured-Deposits-2012-13-to-2018-19.pdf 2023-07-29T09:43:59+00:00 0.51 https://alembicpharmaceuticals.com/llms.txt https://alembicpharmaceuticals.com/llm.txt 2023-07-29T09:43:59+00:00 0.51